SCHEMBL1798356

SCHEMBL1798356

O=C(COCC(=O)N1CCC(OC(c2ccccc2)c2ccccc2)CC1)Nc1ccc(Cl)cc1C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SERPINE1 P05121 3/20 0.71
▸ POLB P06746 2/20 0.45
▸ G6PD P11413 1/20 0.45
▸ BCHE P06276 3/20 0.45
▸ KDM4E B2RXH2 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ EPHX2 P34913 1/20 0.41
▸ PRSS12 P56730 1/20 0.41
▸ GRM5 P41594 1/20 0.40
▸ MAPK1 P28482 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ MGLL Q99685 1/20 0.39
▸ TRPM4 Q8TD43 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1796028 0.92 SERPINE1 (0.61) SERPINE1POLBBCHEKDM4EGAA
SCHEMBL1796185 0.92 SERPINE1 (0.61) SERPINE1POLBG6PDBCHEKDM4E
SCHEMBL1798357 0.84 SERPINE1 (0.62) SERPINE1POLBG6PDKDM4EGAA
SCHEMBL1798984 0.83 SERPINE1 (1.00) SERPINE1POLBG6PD
SCHEMBL29351719 0.83 SERPINE1 (0.98) SERPINE1POLBG6PD
SCHEMBL1799860 0.83 SERPINE1 (0.98) SERPINE1POLBG6PD
SCHEMBL1798325 0.79 SERPINE1 (0.69) SERPINE1POLBG6PDKDM4EGAA
SCHEMBL1796908 0.79 SERPINE1 (0.71) SERPINE1POLBG6PDKDM4EGAA
SCHEMBL1797842 0.78 SERPINE1 (0.68) SERPINE1POLBG6PDKDM4EGAA
Hydrochloric Acid SCHEMBL1797709 0.78 SERPINE1 (0.70) SERPINE1POLBG6PDKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 — — US claimed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 — — US claimed
US-10092537-B2 Use for PAI-1 inhibitor RENASCIENCE CO., LTD. (JP) 2018-10-09 — — US disclosed
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2016-06-09 — — US disclosed
EP-2990057-A1 NOVEL USE FOR PAI-1 INHIBITOR Renascience Co., Ltd. (JP) 2016-03-02 — — EP disclosed
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 — — US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885POLB 2824/4885G6PD 387/4885
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885POLB 2674/4885G6PD 815/4885
US-10092537-B2 Use for PAI-1 inhibitor SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885POLB 2556/4885G6PD 254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback